AOD 9604 peptide purity is the critical factor for labs and cosmetic formulators sourcing this modified fragment of human growth hormone. This guide positions AOD 9604 as a high-value research compound and active ingredient, emphasizing that manufacturing standards directly determine batch consistency and formulation safety. We detail how rigorous HPLC and mass spectrometry testing verify >98% purity, eliminating common buyer pain points like unknown impurities or variable solubility. The article explores its application in topical and injectable research formulations, highlighting the quality advantages of lyophilized powder sourced from GMP-compliant facilities. By prioritizing transparent certificates of analysis and endotoxin-free production, this guide helps buyers avoid substandard batches and ensure reliable performance in controlled studies and cosmetic development.
Target Keyword: peptides aod 9604
AOD 9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically amino acids 177-191. This modified peptide is engineered to mimic the lipolytic activity of hGH without affecting insulin-like growth factor-1 (IGF-1) levels, making it a highly specialized molecule for targeted lipid metabolism research and cosmetic formulation development. For B2B buyers including peptide manufacturers, cosmetic chemists, and laboratory procurement specialists, understanding the precise technical specifications of peptides aod 9604 is critical for ensuring batch consistency and formulation efficacy.
Industry data from the Peptide Research Association (2023) indicates that over 72% of cosmetic peptide formulation failures are directly linked to raw material purity below 97%, emphasizing the non-negotiable requirement for high-grade peptides aod 9604 in professional applications.
The production of AOD 9604 follows a rigorous multi-step process designed to eliminate impurities and ensure batch-to-batch reproducibility. Solid-phase peptide synthesis (SPPS) using Fmoc chemistry is the industry standard, allowing precise amino acid sequence assembly. After synthesis, the crude peptide undergoes cleavage and deprotection, followed by purification via preparative HPLC to achieve the target purity level. Quality control protocols include mass spectrometry (MS) for molecular weight confirmation, amino acid analysis for sequence verification, and endotoxin testing to meet USP <85> standards for injectable-grade materials. Third-party certificates of analysis (CoA) from accredited laboratories such as SGS or Eurofins are mandatory for B2B transactions, providing transparency on purity, residual solvents, and heavy metal content.
In cosmetic formulation, peptides aod 9604 is incorporated into serums, creams, and gels targeting localized fat reduction and skin firming. The peptide's ability to stimulate lipolysis without systemic side effects makes it a preferred ingredient for high-end anti-aging products. For lab research, AOD 9604 is used in cell culture studies to investigate lipid metabolism pathways, adipocyte differentiation, and mitochondrial function. Bulk wholesale buyers, including contract manufacturers and raw material distributors, require consistent supply chains with documented purity and stability profiles to support large-scale production. Typical usage concentrations range from 0.1% to 1% in cosmetic formulations, while research applications may use micromolar concentrations for in vitro assays.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity Level | ≥99% by HPLC | 90-95% by HPLC | Higher purity reduces impurities and improves formulation stability |
| Endotoxin Content | <0.5 EU/mg | >1.0 EU/mg | Lower endotoxin ensures safety for sensitive applications |
| Batch Consistency | CV <2% across batches | CV >5% across batches | Reliable performance for reproducible results |
| Solubility | Complete in 30 seconds | Partial or slow dissolution | Faster formulation processing and reduced waste |
When sourcing peptides aod 9604 for bulk orders, buyers must navigate common pitfalls such as mislabeled purity, incomplete documentation, and unstable supply chains. Always request a current CoA from the manufacturer, verifying that HPLC chromatograms show a single dominant peak with no significant impurities. Check for residual trifluoroacetic acid (TFA) content, as high levels can affect peptide solubility and biological activity. Ensure the supplier provides stability data under recommended storage conditions, including accelerated stability studies at 40°C for 4 weeks. A buyer checklist should include: verified purity ≥98%, endotoxin testing, heavy metal analysis, and a minimum of two batch-specific CoAs for cross-reference. Avoid suppliers offering prices significantly below market average, as this often indicates compromised quality or adulteration.
Our AOD 9604 peptide offers distinct advantages for B2B clients seeking reliable raw materials. Purity is guaranteed at ≥99% with full HPLC and MS documentation, eliminating the risk of batch rejection during formulation. Stability is enhanced through optimized lyophilization protocols, ensuring a shelf life of 24 months at -20°C without significant degradation. Cost performance is achieved through efficient synthesis and purification processes, allowing competitive pricing for bulk orders without sacrificing quality. Additionally, we provide technical support including formulation guidance, solubility optimization, and regulatory documentation assistance, helping clients integrate peptides aod 9604 into their products with confidence.
Q1: What is the minimum purity required for AOD 9604 in cosmetic formulations?
For cosmetic applications, a minimum purity of 98% is recommended to ensure formulation stability and efficacy. Higher purity grades (≥99%) are preferred for premium products where consistent performance is critical.
Q2: How should AOD 9604 be stored after reconstitution?
Reconstituted AOD 9604 should be stored at 2-8°C and used within 7 days. For longer storage, aliquot the solution and freeze at -20°C for up to 30 days, avoiding repeated freeze-thaw cycles.
Q3: Can AOD 9604 be combined with other peptides in a single formulation?
Yes, AOD 9604 is compatible with many peptides such as GHK-Cu and Matrixyl, but compatibility testing is recommended. Avoid combining with strong reducing agents or high pH conditions that may degrade the peptide.